An orange mutant named 'Hong Anliu' (HAL, *Citrus sinensis* cv. Hong Anliu) was first characterized by its high accumulation of lycopene, lower acid and higher soluble sugars in the fruit juice sacs during the ripening stage[@b1]. A recent metabolic analysis by Pan *et al*.[@b2] indicated that many secondary metabolites, such as flavonoids, amino acids and lipids, also showed significant differences compared with the wild type orange 'Anliu' (AL). In the past few years, many researches have been done to investigate the possible reason for high accumulation of lycopene in 'HAL'[@b1][@b3][@b4][@b5][@b6]. Although precious researches also identified many differentially expressed genes or differential proteins in 'HAL' as compared with in 'AL'[@b4][@b5][@b6], a possible mechanism to explain the comprehensive metabolite change in the mutant is not available at present.

In citrus fruit juice sacs, soluble carbohydrates, carotenoids, and some specific secondary metabolites accumulate and organic acid reduces in general as the fruit ripens[@b7][@b8][@b9]. The carbohydrates in the fruits are primarily from the source leaves, whereas the organic acids and other secondary metabolites synthesize locally in the fruits[@b8][@b10]. The carbon skeletons for all the locally synthesized metabolites come from carbohydrate catabolism through glycolysis and the tricarboxylic acid (TCA) cycle. Glycolysis is the metabolic pathway that converts glucose into pyruvate, which transports actively into the mitochondrion where it oxidizes to produce acetyl-CoA or forms oxaloacetate (OAA) by the carboxylation. Moreover, phosphoenolpyruvate (PEP), which is an intermediate in glycolysis, can also form OAA by the catalysis of phosphoenolpyruvate carboxylase (PEPC, EC4.1.1.31). The TCA cycle begins with the condensation of acetyl-CoA and OAA to form citrate catalyzed by citrate synthase (CS, EC2.3.3.1). Subsequently, aconitase (Aco, EC4.2.1.3) isomerizes the citrate to isocitrate. Then, isocitrate dehydrogenase (IDH, EC1.1.1.42) dehydrogenizes the resulting isocitrate to yield α-ketoglutarate (α-KG), which converts to succinyl-CoA by the catalysis of α-ketoglutarate dehydrogenase. The succinyl-CoA undergoes four steps to produce OAA via the formation of succinate, fumarate, and malate catalyzed by succinyl-CoA synthetase, succinate dehydrogenase, fumarase, and malate dehydrogenase, respectively[@b11]. Notably, the carboxylic acids in the TCA cycle connect a larger metabolic networks[@b11]. For example, OAA, fumarate, and α-KG are involved in amino acid biosynthesis/degradation, ammonia assimilation and/or purine nucleotide metabolism/biosynthesis. Malate involves in the glyoxylate cycle and the formation of pyruvate. Moreover, the products of degrading citrate relate to the biosynthesis of γ-aminobutyric acid (GABA)[@b12], isoprenoids, flavonoids and fatty acid extension[@b13][@b14]. In addition, OAA, one of the products of degrading citrate by ATP citrate lyase (ACL, EC4.1.3.8), can reenter the TCA cycle or be utilized for mono- or disaccharide synthesis through the gluconeogenesis pathway, which includes three key enzymes: glucose-6-phosphatase, fructose-1,6-bisphosphatase (FBPase, EC 3.1.3.11), and phosphoenolpyruvate carboxykinase (PEPCK, EC 4.1.1.49)[@b11][@b15].

Acidity is important for the fruit's organoleptic quality. In the citrus juice cell, acidity is generally dependent on citrate accumulation in the cell vacuole where the citrate contributes more than 90% of the total organic acids[@b8]. Citrate accumulation in the vacuole depends on the balance of citrate synthesis, membrane transport and degradation or utilization[@b12][@b16]. CS activity may not be responsible for the difference of acidity among citrus varieties[@b17][@b18]. However, a partial block of mitochondrial Aco (myt-Aco) activity (possibly by citramalate) is the prerequisite for citrate transport into the cell cytoplasm[@b16][@b19]. When citrate transports into the cytoplasm, vacuolar-type proton pumps play an important role in citrate uptake into the vacuole[@b20][@b21][@b22]. Also, some p-type proton pumps relate to citrate accumulation in the vacuole[@b23][@b24]. As the fruit ripens, vacuolar citrate fluxes into the cytoplasm possibly through citrate/H^+^ symporters[@b25] and is utilized through the Aco-GABA and/or ACL-degradation pathway(s)[@b10][@b12][@b26]. Transcript analysis confirmed that the H^+^/citrate symporter CsCit1[@b25], the cytosolic Aco (cyt-Aco), cyt-IDH or NADP-IDH, glutamate decarboxylase (GAD, EC 4.1.1.15), and ACL participate in citrate catabolism as the fruit ripens[@b12][@b16][@b26][@b27][@b28][@b29][@b30][@b31]. Moreover, modifying the process of citrate biosynthesis to utilization can result in a metabolic shift towards amino acid or flavonoid biosynthesis[@b28][@b32].

Because the reactions involved in carboxylic acid metabolism are the central point of the biosynthesis and/or catabolic networks of other metabolites, we hypothesized that the comprehensive variation in metabolites in 'HAL' compared with 'AL' should be tightly related to the changes in citrate metabolism. Hence, we compared the profiles of citrate accumulation-related genes and/or enzyme activities, as well as the metabolic fingerprinting between 'HAL' and 'AL' in the present study to elucidate the possible mechanism underlying the extensive metabolite changes in 'HAL'. These results provide a scenario for this mutant and for the investigation of the network of metabolites involved in fruit quality.

Results
=======

Differential metabolites between 'AL' and 'HAL'
-----------------------------------------------

The high reproducibility of the total ion current of all samples indicated that the raw LC-MS data quality was reliable ([Fig. S1](#S1){ref-type="supplementary-material"}). Using the optimized LC-MS analysis protocol and subsequent processes (i.e., raw data conversion, peak alignment and normalization, extraction of the peak m/z value, and retention time), we obtained 1645 features (one m/z value refers to one feature) under positive mode and 1388 features under negative mode. The relative standard deviation (RSD) frequency distributions of group 'AL' and group 'HAL' were primarily in the 0--30% range under either the positive mode or negative mode ([Fig. S2](#S1){ref-type="supplementary-material"}), indicating that the sample deviation in each group was small and that the data quality was acceptable. The principal component analysis (PCA) and partial least squares-discriminant analysis (PLS-DA) confirmed that significant difference in metabolites exists between group 'AL' and group 'HAL' ([Fig. S3](#S1){ref-type="supplementary-material"}). This PCA result explained 57.8% of the variation in the metabolic profiling (R^2^X = 0.578) under positive mode ([Fig. S3A](#S1){ref-type="supplementary-material"}) and 58.3% of the variation in the metabolic profiling (R^2^X = 0.583) under negative mode ([Fig. S3B](#S1){ref-type="supplementary-material"}). The PLS-DA model achieved a distinct separation between the metabolite fingerprinting of the groups 'AL' and 'HAL' with R^2^X = 0.463, R^2^Y = 0.994, and Q^2^ = 0.997 under positive mode ([Fig. S3C](#S1){ref-type="supplementary-material"}) and R^2^X = 0.459, R^2^Y = 0.997, and Q^2^ = 0.983 under negative mode ([Fig. S3D](#S1){ref-type="supplementary-material"}).

The volcano plot visually displayed many features that significantly differed between 'AL' and 'HAL' ([Fig. S4](#S1){ref-type="supplementary-material"}). According to the screening criteria \[the variable importance in the projection (VIP) \>1 and *p*-value \< 0.01\], we found 718 and 643 features showing significant difference between 'AL' and 'HAL' ([Table S1](#S1){ref-type="supplementary-material"}) under positive and negative modes, respectively. However, we only identified 33 and 39 metabolites under the positive and negative modes, respectively, by searching the METLIN database (<https://metlin.scripps.edu/>) and the BGI-Tech local KEGG metabolite databases with the m/z values. The total number of identified metabolites was 68 ([Table 1](#t1){ref-type="table"}). We further classified these metabolites into seven groups: organic acids, sugars, amino acids and derivatives, purine or pyrimidine nucleosides and analogues, plant hormones and analogues, vitamins and derivatives, and anonymous group ([Table 1](#t1){ref-type="table"}). In the groups of organic acid and sugars, pyruvic acid, citric acid, oxoglutaric acid, isocitric acid, and hexose 1-phosphate had significantly lower levels in 'HAL' compared with 'AL'; their levels in 'HAL' were approximately half or less of their levels in 'AL'. Conversely, the succinic acid, fumaric acid, malic acid, citramalic acid, sucrose, sucrose 6-phosphate, D-glucose 6-phosphate, and 3-O-alpha-L-arabinopyranosyl-L-arabinose contents were significantly higher in 'HAL' than 'AL'. In particular, the succinic acid, sucrose, and 3-O-alpha-L-arabinopyranosyl-L-arabinose contents in 'HAL' were 2-fold higher than those in 'AL'. In the amino acids and derivatives group, the L-lysine and histidinol phosphate levels were significantly lower in 'HAL' than in 'AL', whereas the histidine, serine, threonine, pyrroline hydroxycarboxylic acid, and phenylpyruvic acid levels were significantly higher in 'HAL' than in 'AL'. Notably, the L-lysine level in 'HAL' was less than one-tenth the level in 'AL', whereas the histidine level under negative mode and the pyrroline hydroxycarboxylic acid level under positive mode were more than 2- and 4-fold higher in 'HAL' than in 'AL', respectively. In the purine or pyrimidine nucleosides and analogues groups, all identified metabolites, including guanosine, deoxyinosine, uridine, uracil, and hypoxanthine, had significantly higher levels in 'HAL' compared with 'AL'. Specifically, the levels of uridine and deoxyinosine were more than 6- and 28-fold higher in 'HAL' than in 'AL', respectively. In the plant hormones and analogues group, abscisic acid (ABA), abscisic alcohol 11-glucoside, and methyl jasmonate (MeJA) showed significantly lower levels in 'HAL' compared with 'AL', whereas the levels of zeatin analogues and dihomo-jasmonic acid were significantly higher in 'HAL' than in 'AL'. In the vitamins and derivatives group, four types of metabolites exhibited significant differences between the two cultivars. In them, the levels of ascorbic acid, L-ascorbic acid-2-glucoside, and niacin were nearly 2-fold higher in 'HAL' than in 'AL', whereas the riboflavin content in 'HAL' was less than half of the riboflavin content in 'AL'. In addition, we clustered 32 identified metabolites into the anonymous group due to their complex or unclear functions. In them, 15 metabolites had significantly lower levels and 17 metabolites had significantly higher levels in 'HAL' compared with 'AL'. The isopentenyl adenosine-5′-diphosphate, propyl cinnamate, and limonexic acid contents in 'HAL' were one-fourth or less of the contents in 'AL', whereas the levels of rhamnocitrin 3-(6′-acetylglucoside), methyl pentenoic acid, and cinnamic acid were increased by 3.5-fold and the octenoic acid level was increased by 20-fold in 'HAL' compared with 'AL'.

Comparative analysis of citrate biosynthesis-related enzymes
------------------------------------------------------------

CS catalyzes the condensation of acetyl-CoA and OAA to form citrate and PEPC catalyzes the β-carboxylation of phosphoenolpyruvate to produce OAA. CS is directly responsible for citrate synthesis, whereas PEPC has been suggested to influence citrate biosynthesis[@b33]. Although one PEPC gene and one CS gene were previously cloned from citrus[@b17][@b18][@b33], we further screened the citrus genome databases and the PCR confirmation indicated that there were at least three PEPC and two CS gene members in the current citrus genome databases ([Table S2](#S1){ref-type="supplementary-material"}, [Fig. S5A,B](#S1){ref-type="supplementary-material"}). Then, we analyzed their expression levels in both the 'AL' and 'HAL' fruit juice sacs at 235 days after florescence (DAF) ([Fig. 1a,b](#f1){ref-type="fig"}). The *PEPC*1 and *PEPC*2 transcript levels were significantly higher in 'HAL' than 'AL', whereas the *PEPC*3 transcript level in 'HAL' was markedly lower than that in 'AL' ([Fig. 1a](#f1){ref-type="fig"}). In contrast to the three PEPC genes, the transcript levels of the two CS genes were both significantly higher in 'HAL' than 'AL' ([Fig. 1b](#f1){ref-type="fig"}). We further analyzed their enzyme activities and found that the PEPC ([Fig. 1a1](#f1){ref-type="fig"}) and CS ([Fig. 1b1](#f1){ref-type="fig"}) activities were significantly higher in 'HAL' than 'AL'.

Comparative analysis of citrate transport-related genes
-------------------------------------------------------

The expression profiles of the genes encoding vacuolar H^+^-ATPase (VHA), the vacuolar H^+^-PPase (VHP), *CsPH8* encoding the P-type proton pump[@b23] and *CsCit1*[@b25] were compared between 'AL' and 'HAL' ([Fig. 2](#f2){ref-type="fig"}).

VHA consists of a peripheral V1 domain and a membrane-integral V0 domain. VHA contains 13 subunits (VHA-A, VHA-B, VHA-C, VHA-D, VHA-E, VHA-F, VHA-G, and VHA-H for the V1 domain and VHA-a, VHA-c, VHA-c", VHA-d, and VHA-e for the V0 domain); moreover, there is an assembly factor (af) for VHA assembly[@b34]. Through screening the citrus genome databases and PCR confirmation, we found at least one gene encoding af, VHA-A, B, C, D, G, c", d, and e, two genes encoding VHA-E, F, H, and a, and four genes encoding VHA-c ([Table S2](#S1){ref-type="supplementary-material"}, [Fig. S5F--H](#S1){ref-type="supplementary-material"}). Transcript analysis indicated that the *VHA-af* transcript level of 'HAL' was half that of 'AL' ([Fig. 2a](#f2){ref-type="fig"}). Moreover, the transcript levels of some genes (i.e., *VHA-D*, *VHA-H2*, *VHA-c4*, *VHA-d*, and *VHA-e*) were extremely or significantly lower, whereas the transcript levels of *VHA-H1*, *VHA-c1*, and *VHA-c3* were significantly higher in 'HAL' than 'AL'. Additionally, the transcript levels of other genes encoding the VHA V1 and V0 domains showed no significant difference between the two cultivars ([Fig. 2a,b](#f2){ref-type="fig"}). VHP is another V-type proton pump[@b35]. Inquiry of the citrus genome and PCR confirmation indicated the presence of at least four genes (*VHP1-4*) encoding VHP ([Table S1](#S1){ref-type="supplementary-material"} and [Fig. S5I](#S1){ref-type="supplementary-material"}). Transcript analysis showed that the transcript levels of *VHP1-4* were significantly lower in 'HAL' than 'AL' ([Fig. 2c](#f2){ref-type="fig"}). Similar to *VHP1-4*, the *CsPH8* transcript level was also significantly lower in 'HAL' than 'AL'. However, the *CsCit1* transcript level had no significant difference between 'HAL' and 'AL' ([Fig. 2d](#f2){ref-type="fig"}).

Comparative analysis of citrate degradation- or utilization-related genes and/or enzyme activities
--------------------------------------------------------------------------------------------------

Citrate participates in the TCA cycle primarily for energy metabolism in the mitochondria[@b11]. In the cell cytoplasm, citrate can use for amino acid or GABA biosynthesis through the production of glutamate[@b12][@b28], for the biosynthesis of many secondary metabolites and for gluconeogenesis through the ACL-degradation pathway[@b10][@b13][@b26][@b36].

Aco, IDH, GS and GAD are the key enzymes involved in citrate catabolism through the Aco-GABA pathway ([Fig. 3](#f3){ref-type="fig"}). A previous study indicated that three genes (*Aco1*, *Aco2* and *Aco3*) encode Aco in the citrus genome[@b29]. Here, transcript analysis showed that the *Aco1* transcript level in 'HAL' was slightly higher than that of 'AL' and the *Aco2* and *Aco3* transcript levels were more than six-fold higher in 'HAL' than in 'AL' ([Fig. 3a](#f3){ref-type="fig"}). Enzyme activity analysis showed that the mit-Aco activity was significantly lower ([Fig. 3a1](#f3){ref-type="fig"}) and the cyt-Aco activity was significantly higher ([Fig. 3a2](#f3){ref-type="fig"}) in 'HAL' than 'AL'. IDH is the second key enzyme involved in citrate catabolism. One gene encoding cyt-IDH or NADP-IDH was cloned from citrus by Sadka *et al*.[@b30]. In this study, inquiry of the citrus genome databases and PCR confirmation showed that at least three NAD-IDH (mitochondrial type) and NADP-IDH (cytoplasmic type) genes exist in the citrus genome ([Table S1](#S1){ref-type="supplementary-material"} and [Fig. S5C,D](#S1){ref-type="supplementary-material"}). Transcript analysis indicated that the transcript levels of the three NAD-IDH genes ([Fig. 3b](#f3){ref-type="fig"}) and two NADP-IDH genes (*NADP-IDH1* and *NADP-IDH3*, [Fig. 3c](#f3){ref-type="fig"}) were significantly higher in 'HAL' than 'AL'. Moreover, the enzyme activity analysis showed that the activities of myt-IDH ([Fig. 3](#f3){ref-type="fig"}b[1](#f1){ref-type="fig"}) and cyt-IDH ([Fig. 3](#f3){ref-type="fig"}c[1](#f1){ref-type="fig"}) were both significantly higher in 'HAL' than 'AL'. GS and GAD are two enzymes that catalyze glutamate in the cytoplasm ([Fig. 3](#f3){ref-type="fig"}). Three genes (*GS1*-*3*) encoding GS were confirmed in the citrus genome ([Table S1](#S1){ref-type="supplementary-material"} and [Fig. S5B](#S1){ref-type="supplementary-material"}) and two genes (*GAD1*-*2*) were previously confirmed by Liu *et al*.[@b31]. Transcript analysis indicated that the transcript levels of *GS2* ([Fig. 3d](#f3){ref-type="fig"}), *GS3* ([Fig. 3d](#f3){ref-type="fig"}) and *GAD2* ([Fig. 3e](#f3){ref-type="fig"}) were significantly higher in 'HAL' than 'AL'. Differently, the *GS1* transcript level was similar between 'HAL' and 'AL' ([Fig. 3d](#f3){ref-type="fig"}) and the *GAD1* transcript level was significantly lower in 'HAL' than 'AL' ([Fig. 3e](#f3){ref-type="fig"}). Furthermore, the enzyme activities of GS and GAD showed similar levels between 'HAL' and 'AL' ([Fig. 3d,e](#f3){ref-type="fig"}).

ACL catalyzes the cleavage of citrate to yield acetyl-CoA and OAA, which involve in the biosynthesis of many secondary metabolites or gluconeogenesis ([Fig. 3](#f3){ref-type="fig"}). Three ACL genes have been confirmed in the citrus genome[@b26]. Here, transcript analysis showed that the transcript levels *of ACLα*1, *ACLα*2 and *ACLβ* were more four-fold higher in 'HAL' than 'AL' ([Fig. 3f](#f3){ref-type="fig"}). Moreover, the ACL enzyme activity in 'HAL' was significantly higher than that in 'AL' ([Fig. 3f1](#f3){ref-type="fig"}).

The PEPCK and FBPase are the key enzymes involving in gluconeogenesis[@b11][@b15]. The sequence inquiry and PCR confirmation indicated that at least two genes encoding PEPCK and FBPase exist in the citrus genome ([Table S1](#S1){ref-type="supplementary-material"}, [Fig. S5A,E](#S1){ref-type="supplementary-material"}). The *PEPCK1* transcript level was significantly lower and the *PEPCK2* transcript level was significantly higher in 'HAL' than 'AL' ([Fig. 3g](#f3){ref-type="fig"}). Differently from the PEPCK genes, the transcript levels of the *FBPase1* and *FBPase2* genes were both significantly higher in 'HAL' than 'AL' ([Fig. 3h](#f3){ref-type="fig"}).

Discussion
==========

'HAL' is a bud mutant of the 'AL' sweet orange[@b1]. It is characterized by a comprehensive alteration in metabolites, such as the lycopene, the soluble sugars (sucrose, fructose and glucose), the organic acids and other secondary metabolites[@b1][@b2][@b4]. To help investigating the possible reason for the comprehensive change, we analyzed the metabolites in the fruits of the two cultivars at 242 DAF by using LC-Q/TOF-MS technique in the present study. Although we found more than 600 features showing significant difference between the two cultivars under the current analysis conditions ([Table S1](#S1){ref-type="supplementary-material"}), only approximately one-tenth of the different features were identified ([Table 1](#t1){ref-type="table"}). Nevertheless, the profiles of differently identified metabolites between the two cultivars were almost consistent with the report of Pan *et al*.[@b2], implying that the data is believable.

As the carboxylic acid metabolism is the central point of the biosynthesis and/or catabolic networks of other metabolites, we further assessed the significance of citrate metabolism in the comprehensive metabolite alterations in 'HAL'. Clearly, citrate is significantly lower in the juice sacs of 'HAL' than 'AL' during fruit development and ripening[@b1][@b4], which was further confirmed in the present study ([Table 1](#t1){ref-type="table"}). However, we found that the transcript levels of citrate biosynthesis-related genes (*CS*1, *CS*2, *PEPC*1, *PEPC*2) and the enzyme activities of CS and PEPC were significantly higher in 'HAL' than 'AL' ([Fig. 1](#f1){ref-type="fig"}), indicating that 'HAL' has an increased citrate biosynthesis ability compared with 'AL'. Thus, we can deny the hypothesis that the low accumulation of citrate in 'HAL' is possibly due to the reduction of citrate biosynthesis.

It is well known that a partial block of myt-Aco activity is a prerequisite for citrate transport into the cell cytoplasm[@b16][@b19]. Bogin and Wallace[@b19] first suggested that the citramalate was possibly the inhibitor of myt-Aco. Degu *et al*.[@b28] found that spraying citramalate did inhibit Aco activity and increased citrate accumulation in citrus fruit juice sacs. Consistent with the study of Pan *et al*.[@b2], we found that the citramalate or citramalic acid content was significantly higher (1.24-fold) in 'HAL' than 'AL' ([Table 1](#t1){ref-type="table"}), moreover, the myt-Aco activity was significantly lower in 'HAL' than 'AL' ([Fig. 3a1](#f3){ref-type="fig"}). These results implied that more citrate in the mitochondrion transports into the cytoplasm in 'HAL' than 'AL'.

When citrate transports into the cytoplasm, it should utilize immediately or store quickly in the vacuole to keep the cytoplasm neutral for cell activity[@b15][@b37]. The uptake of citrate into the vacuole depends on the activity of the proton pumps[@b21][@b22] and the utilization of citrate depends on the activities of enzymes involved in Aco-GABA pathway[@b12] and/or ACL-pathway[@b26]. Here, we found that some key VHA genes ([Fig. 2a,b](#f2){ref-type="fig"}) \[e.g., the VHA assembly factor gene (*VHA-af*), all the VHP genes ([Fig. 2c](#f2){ref-type="fig"}), and the juice sac-predominant p-type proton pump gene (*CsPH*8)[@b23]\] showed significantly lower expression levels in 'HAL' than 'AL'. On the other hand, the activities of cyt-Aco and NADP-IDH in the Aco-GABA pathway and ACL in the ACL-degradation pathway were significantly higher in 'HAL' than 'AL' ([Fig. 3](#f3){ref-type="fig"}). These results indicated that in the 'HAL', more citrate does not accumulate in the vacuole but utilizes in the cytoplasm because the lower expression levels of proton pump genes reduce the ability of the proton pump to uptake citrate into the vacuole. Moreover, the higher enzyme activities of cyt-Aco, NADP-IDH and ACL increase the ability to utilize citrate.

The TCA cycle is very important for organisms by generating energy and providing various precursors for other biochemical reactions[@b11]. The present study showed that the citramalate content increased significantly ([Table 1](#t1){ref-type="table"}) and the myt-Aco activity reduced clearly ([Fig. 3a1](#f3){ref-type="fig"}), suggesting that the TCA cycle should be seriously blocked in 'HAL' compared with 'AL'. However, we also found that the cyt-Aco ([Fig. 3a2](#f3){ref-type="fig"}) and NADP-IDH ([Fig. 3c1](#f3){ref-type="fig"}) activities increased significantly in 'HAL' compared with 'AL' and the activities of GS ([Fig. 3d1](#f3){ref-type="fig"}) and GAD ([Fig. 3e1](#f3){ref-type="fig"}) of which both enzymes catalyze glutamate showed similar levels between 'HAL' and 'AL'. These results suggested that the direct products (isocitrate and α-KG) of cyt-Aco and NADP-IDH should be significantly higher in 'HAL' than 'AL'. Nevertheless, they decreased significantly in 'HAL' compared with 'AL' ([Table 1](#t1){ref-type="table"}). Therefore, we inferred that more cytoplastic isocitrate and α-KG in 'HAL' import into the mitochondrion and participate in the TCA cycle again. The compensation of isocitrate and α-KG from the catalysis of cytoplastic citrate by cyt-Aco and NADP-IDH contributes to the stability of the TCA cycle in 'HAL'.

Another cytoplastic citrate-degrading pathway is through ACL catalysis, which links the production of many secondary metabolites[@b13][@b36]. For example, Crifò *et al*.[@b32] suggested that citrate could utilize for flavonoid biosynthesis through ACL catalysis in blood oranges under cold storage. In the present study, the ACL gene transcript levels ([Fig. 3f](#f3){ref-type="fig"}) and enzyme activity ([Fig. 3f1](#f3){ref-type="fig"}) were significantly higher in 'HAL' than 'AL'. These findings indicated that ACL is more active in the low-acid orange 'HAL' than in the normal-acid orange 'AL', implying that more citrate is cleaved to produce more OAA and acetyl-CoA. OAA can reenter into the mitochondrion for citrate biosynthesis or use for gluconeogenesis or amino acid biosynthesis[@b11][@b15]. Here, we found that the transcript levels of three key genes \[*PEPCK2* ([Fig. 3b](#f3){ref-type="fig"}), *FBPase1* and *FBPase2* ([Fig. 3](#f3){ref-type="fig"}h)\] involving in gluconeogenesis, the intermediate sugar (Glu-6P) and the soluble sugar (Suc, Glu, and Fru) contents were significantly higher in 'HAL' than in 'AL' ([Table 1](#t1){ref-type="table"}). These results indicated the OAA from the catalysis of cytoplastic citrate by ACL participates in the gluconeogenesis, which at least accounts partially for the significant increase of the soluble sugars in 'HAL'. Judging from the [Fig. 4](#f4){ref-type="fig"}, the significant increase of Glu-6P at least contributes partially to the significantly increase of ascorbic acid, histidine (His), pyrimidine or purine in 'HAL' compared with 'AL' ([Table 1](#t1){ref-type="table"}). In addition, the contents of serine, glycine and tryptophan were significantly higher in 'HAL' than 'AL' ([Table 1](#t1){ref-type="table"}), which is possibly related to the participation of OAA or pyruvate ([Fig. 4](#f4){ref-type="fig"}). On the other hand, another product of acetyl-CoA via ACL catalysis usually utilizes for fatty acid extension or the biosynthesis of isoprenoids and other secondary metabolites[@b13][@b32][@b36], including the biosynthesis of lysine (Lys), methyl jasmonate (MeJA), zeatin, lycopene or ABA ([Fig. 4](#f4){ref-type="fig"}). The present study showed that the content of zeatin was significantly higher but the contents of Lys, MeJA and ABA were significantly lower in 'HAL' than 'AL' ([Table 1](#t1){ref-type="table"}), consistent with the previous study of Pan *et al*.[@b2]. In addition, we are also sure that lycopene is significantly higher in 'HAL' than 'AL' because lycopene can be visibly found in 'HAL' ([Fig. S6](#S1){ref-type="supplementary-material"}) and has been detected by HPLC at a significant level in 'HAL'[@b1][@b4]. In this study, consistent with a previous metabolomics analysis [@b2], we failed to identify lycopene in 'HAL' possibly due to the lack of a standard reference database for citrus fruits or just using a colomn C18 not a C30 in the LC-MS analysis. Furthermore, we believe that there should have more significantly altered secondary metabolites in 'HAL' because 90% of the differential features failed identification in this study ([Table S1](#S1){ref-type="supplementary-material"} and [Table 1](#t1){ref-type="table"}). This failure is largely due to our basic lack of knowledge of many metabolic pathways in plants and our current inability to identify the majority of metabolites synthesized in the citrus plant.

Taken together, this study confirmed that the orange mutant 'HAL' has a comprehensive alteration in metabolites except for the increase in lycopene and soluble sugars and the decrease in citrate. Combining the present and previous results[@b1][@b2][@b3][@b4][@b6], we established a model to explain the comprehensive alteration in metabolites in the orange mutant 'HAL' ([Fig. 4](#f4){ref-type="fig"}). In detail, although the citrate content is very low in 'HAL' juice sacs, 'HAL' still has higher ability to biosynthesize the citrate comprared with 'AL'. Moreover, the citramalate content (the inhibitor of mit-Aco) increases significantly and the mit-Aco activity decreases significantly in 'HAL', resulting in more synthesized citrate exports into the cytoplasm. Because the transcript levels of some key genes of proton pump decreases significantly in 'HAL' compared with 'AL', which reduces the ability for the uptake of citrate into the vacuole, more citrate cannot store in the vacuole. The abundant citrate utilize immediately because the activities of cys-Aco, NADP-IDH and ACL increase significantly in the 'HAL' compared with the 'AL', which keeps the cytoplasmic pH constant. Some citrate-splitting products possibly reenter the mitochondrion to maintain the stability of the TCA cycle rather than participate in the biosynthesis of GABA or glutamine. The others utilize for gluconeogenesis and/or secondary metabolite metabolism, which results in a significant increase in the soluble sugars, ascorbic acid, histidine, pyrimidine, purine, zeatin, and lycopene or a significant decrease in methyl jasmonate and ABA ([Fig. 4](#f4){ref-type="fig"}).

Frankly, the model gives a rough but reasonable explanation for the comprehensive change in metabolites of 'HAL' compared with its wild type, 'AL'. In the model, the decrease of proton pump genes' expression, namely, the reduction of proton pump ability to promote the citrate storing in the vacuole plays a pivotal role for the comprehensive alteration in metabolites of 'HAL'. Although the lower ABA content in the 'HAL' compared with 'AL' is possibly due to the higher accumulation of lycopene in 'HAL', which always reduces ABA biosynthesis[@b1][@b38], there is a long way to verify this model in the future because of the complexity in the secondary metabolism and the difficulty for gene function identification of perennial plants.

Methods
=======

Plant materials and sample preparation
--------------------------------------

The 'Anliu' sweet orange (AL, *Citrus sinensis* cv. Anliu) and its mutant 'Hong Anliu' (HAL, *C. sinensis* cv. Hong Anliu) grafted onto the same rootstock (trifoliate orange as base rootstock and Satsuma mandarin as middle rootstock) at the citrus germplasm orchard in Huazhong Agricultural University (Hubei province, China) were used in the present study ([Fig. S6](#S1){ref-type="supplementary-material"}). We collected ten nearly uniform fruits of each cultivar randomly at 235 DAF for the gene expression and enzyme activity analyses. Because the metabolite response occurs later than the gene reaction, we collected another ten fruits collected at 242 DAF (seven-day interval) for the metabolite analysis. The fruit segments were separated immediately, frozen in liquid nitrogen and stored at −80 °C prior to use.

LC-MS analysis
--------------

Ten fruits (n = 10) of 'AL' and 'HAL', respectively at 242 DAF were sent to BGI TechSolutions Co., Ltd. (BGI-Tech, Shenzhen, China) for metabolite analysis. One segment was randomly selected from each fruit and ground into powder in liquid nitrogen. The powder was ultrasonically oscillated with 800 μL of solvent (acetonitrile:water = 7:3) for 20 minutes. A total of 300 μL of homogenate was transferred into a clean Eppendorf tube and centrifuged for 10 min at 12,000 × g and 4 °C. A total of 100 μL of the supernatant was used for the sample injection.

The detection instrument was the LC-Q/TOF-MS (Agilent, 1290 Infinity LC, 6530 UHD and Accurate-Mass Q-TOF/MS) with a C~18~ chromatographic column (Agilent, 100 mm × 2.1 mm, 1.8 μm). The separation conditions were as follows: column temperature, 40 °C; flow rate, 0.35 mL/min; pressure limit, 800 bar; mobile phase A, 0.1% formic acid in water (v/v); mobile phase B, 0.1% formic acid in acetonitrile (v/v); and injection volume and temperature, 4 μL and 4 °C. The elution gradient was 5% mobile phase B at 0 and 1 min, 20% at 6 min, 50% at 9 min, and 95% at 13 and 15 min.

Sample analysis performed under the positive and negative ion modes and their mass parameters showed in [Table S3](#S1){ref-type="supplementary-material"}. Nitrogen was as the cone or desolvation gas. The ion scan time was 0.03 s with a scan interval of 0.02 s. The mass scanning range was 50--1000 m/z. The data were processed with the standard procedure[@b39][@b40].

Real-time PCR expression analysis
---------------------------------

Total RNAs of the fruit segment samples at 235 DAF were isolated from with the RNAprep Pure Plan Kit (TIANGEN BIOTECH CO., LTD., Beijing, China) according to the manual protocol. One μg of high-quality total RNA was used for first-strand cDNA synthesis using the PrimeScript RT Reagent kit with gDNA Eraser (TaKaRa, DALIAN, China). The citrate-accumulated genes used here included three *PEPC*s, two *CS*s, one *CsCit1*[@b25], three *Aco*s[@b29], three *NAD-IDH*s, three *NADP-IDH*s, three glutamine synthetases (EC 6.3.1.2) (*GS*s), two GADs[@b31], three ACLs[@b26], one p-type proton pump gene (*CsPH*8)[@b23], twenty-four V-type proton pumps, and an assembly factor (af) for vacuolar H^+^-ATPase (VHA) assembly (*VHA-af*). Moreover, two *PEPCK*s and *FBPase*s involved in gluconeogenesis were included. Their sequences were identified from the citrus genome databases (citrus.hzau.edu.cn/orange/and phytozome.jgi.doe.gov/pz/portal.html) followed by PCR confirmation or referenced from other studies ([Table 2](#t2){ref-type="table"}, [Table S2](#S1){ref-type="supplementary-material"} and [Fig. S5](#S1){ref-type="supplementary-material"}). The authenticity of the sequences from the citrus genome databases confirmed by PCR amplification using 'AL' fruit cDNA as the template prior to primer design for the quantitative real-time PCR (qRT-PCR). Primers specific for the targeted genes and the actin gene were designed with Primer 3.0[@b41] and listed in [Table 2](#t2){ref-type="table"} or [Table S2](#S1){ref-type="supplementary-material"}. The qRT-PCR performed in a 10-μL reaction volume using SYBR *Premix Ex Taq* (TaKaRa, DALIAN, China) on a LightCycler 480 Real-Time System according to the manufacturer's protocol. The qRT-PCR carried out for three biological replicates. The reactions started with an initial incubation at 50 °C for 2 min, followed by 95 °C for 10 min and 40 cycles of 95 °C for 15 s and 60 °C for 60 s. The Livak method[@b42] was employed to calculate the relative gene expression level.

Enzyme activity determination
-----------------------------

The determination of each enzyme activity performed in triplicate. The activities of CS, cyt- and myt-ACO, and cyt- and myt-IDH were assayed with the methods reported by Luo *et al*.[@b43] and Hirai and Ueno[@b44]. The ACL activity was analyzed with the method described by Hu *et al*.[@b26], and the GAD activity was assayed with the method described by Liu *et al*.[@b31].

Glutamine synthetase (GS, EC 6.3.1.2) activity was assayed with the method described by Kaiser and Lewis[@b45] with modifications. Two grams of sample were ground into powder with liquid nitrogen. Then, the powder was homogenized with 4 ml of cold extraction buffer (0.1 mM phosphate buffer containing 1 mM EDTA, 2 mM dithiothreitol and 8% insoluble polyvinylpyrrolidone), incubated on ice for 10 min, and centrifuged at 12,000 × g for 15 min at 4 °C. The supernatant stored at 0--4 °C and used as the crude enzyme solution. The enzyme assay was the same as that described by Kaiser and Lewis[@b45], and the absorbance was measured at 540 nm.

Data processing and statistics
------------------------------

Similar with other reports[@b2][@b46], the LC-MS raw data were initially converted into the netCDF format and then processed by the XCMS toolbox (<http://metlin.scripps.edu/xcms/>)[@b47]. After m/z data normalization, the data quality was evaluated by calculating the relative standard deviation (RSD) and drawing the RSD histogram. The data was pre-processed by both mean-centering and variance-scaling prior to multivariate analysis. Then, the resulting scaled datasets were imported into simca-p software (Version 12.0, Umetrics, Umea, Sweden) and the unsupervised PCA and supervised PLS-DA were carried out to test the difference of metabolomic data between groups of 'AL' and 'HAL'. The significantly different features were screened out with the combination of VIP value (\>1) from PLS-DA and the p value (\<0.01) from a two-tailed Student's t-test. The differential m/z candidates were putatively identified through searching the online Metlin database (metlin.scripps.edu/)[@b48] and the local KEGG databases (version 59, BGI TechSolutions Co., Ltd., Shenzhen, China).

On the other hand, the significant difference of gene expression or enzyme activity between 'AL' and 'HAL' at 235 DAF was evaluated with Student's t test in the ANOVA program of SAS (SAS Institute, Cary, NC, USA). Difference was considered significant at P \< 0.05.
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![Gene expression and activity analysis of citrate biosynthesis-related enzymes.\
PEPC, OAA, CS, AL and HAL are the abbreviations of phosphoenolpyruvate carboxylase, oxaloacetate, citrate synthase, 'Anliu' orange and 'Hong Anliu' orange, respectively. (**a**) and (**b**) refer to the results of the PEPC and CS gene expression analysis, respectively. a1 and b1 refer to the activities (U·min^−1^·g^−1^FW) of the PEPC and CS enzymes, respectively. The asterisks (\*) on the bars indicate significant differences (*P* \< 0.05) between the AL and HAL fruits in the *t-*tests (LSD).](srep29343-f1){#f1}

![Expression profiles of the genes involved in citrate transport.\
(**a,b**) refer to the expression profiles of the genes encoding the VHA assembly factor (*af*) or different VHA subunits, respectively (**c**) refers to the expression profiles of the genes encoding VHP (**d**) refers to the expression profiles of *CsPH8* (Shi *et al*.[@b23]) and *CsCit1* (Shimada *et al*.[@b25]). The asterisks (\*) on the bars indicate significant differences (*P* \< 0.05) between the AL and HAL fruits in the *t-*tests (LSD).](srep29343-f2){#f2}

![Comparison of citrate degradation- and utilization-related genes expression levels and/or their respective enzyme activities.\
Aco, IDH, α-KG, GS, GAD, ACL, PEPCK, FBPase, AL and HAL are the abbreviations of aconitase, isocitrate dehydrogenase, α-ketoglutarate, glutamine synthesis, glutamate decarboxylase, ATP-citrate lyase, phosphoenolpyruvate carboxykinase, fructose-1,6-bisphosphatase, 'Anliu' orange and 'Hong Anliu' orange, respectively. a-f refer to the results of the gene expression analysis, respectively. a1 and a2 refer to the activities (U·min^−1^·g^−1^FW) of mitochondrial Aco and cytoplasmic Aco, respectively. b1 and c1 refer to the activities (U·min·g^−1^FW) of NAD-IDH and NADP-IDH, respectively. d1, e1, and f1 refer to the activities of GS (△OD·h^−1^·g^−1^FW), GAD (GABA mg·h^−1^·g^−1^FW), and ACL (μmol·min^−1^·g^−1^FW), respectively. The asterisks (\*) on the bars indicate significant differences (*P* \< 0.05) between the AL and HAL fruits in the *t-*tests (LSD).](srep29343-f3){#f3}

![Overview of the major metabolic pathways involved in mutant trait formation.\
The red circle indicates that the metabolite content, enzyme activity or gene expression level is significantly higher in the mutant cultivar ('HAL') than the wild type cultivar ('AL'). The green circle indicates that the metabolite content, enzyme activity or gene expression level is significantly lower in 'HAL' than 'AL'. The black circle indicates that the difference of other metabolites between 'HAL' and 'AL' is not clear.](srep29343-f4){#f4}

###### Classification of the putatively identified metabolites that were significantly different between 'HAL' (M) and 'AL' (W).

  Classification                                   Putative Name                                  m/z      Retension time (min)   Fold change (M/W)   Detection mode
  ------------------------------------------------ ------------------------------------------ ----------- ---------------------- ------------------- ----------------
  Organic acids                                    Pyruvic acid                                111.00535          1.028                 0.24             POSITIVE
                                                   Citric acid                                 193.03266          1.032                 0.21             POSITIVE
                                                   Citric acid                                 191.02135          1.029                 0.49             NEGATIVE
                                                   Oxoglutaric acid                            147.02684          1.025                 0.26             POSITIVE
                                                   Isocitric acid                              191.02135          1.029                 0.49             NEGATIVE
                                                   Succinic acid                               117.02051          1.404                 2.21             NEGATIVE
                                                   Fumaric acid                                115.00441          0.923                 1.34             NEGATIVE
                                                   Malic acid                                  133.01496          0.925                 1.32             NEGATIVE
                                                   Citramalic acid                             147.03118          1.410                 1.24             NEGATIVE
  Sugars                                           Hexose 1-phosphate                          241.0117           0.726                 0.43             POSITIVE
                                                   D-Glucose 6-phosphate                       259.0243           0.730                 1.43             NEGATIVE
                                                   Sucrose 6-phosphate                         423.08989          5.560                 1.67             NEGATIVE
                                                   3-O-alpha-L-Arabinopyranosyl-L-arabinose    845.27875          0.839                 2.31             NEGATIVE
                                                   Sucrose                                     342.10781          2.830                 2.59             NEGATIVE
  Amino acids and derivatives                      L-Lysine                                    147.11607          8.394                 0.07             POSITIVE
                                                   Histidinol phosphate                        222.06526          6.738                 0.56             POSITIVE
                                                   Threonine                                   118.05209          0.786                 1.45             NEGATIVE
                                                   Serine                                      104.03656          0.774                 1.52             NEGATIVE
                                                   Pyrroline hydroxycarboxylic acid            130.0496           1.207                 1.66             NEGATIVE
                                                   Phenylpyruvic acid                          165.05436          5.136                 1.79             POSITIVE
                                                   Histidine                                   154.06336          0.752                 2.07             NEGATIVE
                                                   Pyrroline hydroxycarboxylic acid            128.03637          1.220                 4.51             POSITIVE
  Purine or pyrimidine nucleosides and analogues   Uracil                                      113.0344           1.207                 1.41             POSITIVE
                                                   Uridine                                     245.07651          1.210                 1.44             POSITIVE
                                                   Guanosine                                   284.09683          1.048                 1.56             POSITIVE
                                                   Hypoxanthine                                135.03158          0.810                 1.75             NEGATIVE
                                                   Uridine                                     243.06432          1.222                 6.08             NEGATIVE
                                                   Deoxyinosine                                251.07958          0.995                 28.27            NEGATIVE
  Plant hormones and analogues                     Abscisic Acid                               265.1434           7.746                 0.46             POSITIVE
                                                   Abscisic Acid                               263.13068          7.746                 0.48             NEGATIVE
                                                   Abscisic alcohol 11-glucoside               411.20525           8.60                 0.51             NEGATIVE
                                                   Methyl jasmonate                            223.13491          7.394                 0.67             NEGATIVE
                                                   trans-Zeatin/Pantothenic Acid               220.11792          2.998                 1.32             POSITIVE
                                                   trans-Zeatin/Pantothenic Acid               218.10499          2.994                 1.45             NEGATIVE
                                                   Cis-zeatin-O-glucoside                      380.15868           3.28                 1.68             NEGATIVE
                                                   dihomo-jasmonic acid                        237.15145          8.615                 1.83             NEGATIVE
  Vitamins and derivatives                         Ascorbic acid                               175.02559          0.933                 1.90             NEGATIVE
                                                   L-Ascorbic acid-2-glucoside                 337.08065          0.908                 1.99             NEGATIVE
                                                   Niacin                                      124.03601          1.041                 1.76             POSITIVE
                                                   Riboflavin                                  375.13283           5.17                 0.48             NEGATIVE
  Anonymous group                                  Isopentenyl adenosine-5′-diphosphate        494.09674           7.45                 0.24             NEGATIVE
                                                   Propyl cinnamate                            191.10609          3.185                 0.25             POSITIVE
                                                   Limonexic acid                              503.19124          7.487                 0.25             POSITIVE
                                                   alpha-Methylstyrene                         119.0854           7.390                 0.42             POSITIVE
                                                   Inositol cyclic phosphate                   241.0117           0.726                 0.43             NEGATIVE
                                                   Ambolic acid                                471.38581          0.674                 0.45             POSITIVE
                                                   Ethylphenol/Dimethylphenol                  123.08023          7.392                 0.45             POSITIVE
                                                   Nicotinate D-ribonucleoside                 256.07836          7.393                 0.46             POSITIVE
                                                   Pyridoxamine-5′-Phosphate                   249.0607           7.390                 0.49             POSITIVE
                                                   L-Citronellol glucoside                     317.19884          7.044                 0.50             NEGATIVE
                                                   Furoic acid                                 111.00918          1.029                 0.52             NEGATIVE
                                                   Ubiquinone-1                                251.12784          7.057                 0.54             POSITIVE
                                                   Propylphenol                                137.09579          6.738                 0.58             POSITIVE
                                                   Viburtinal                                  161.05945          4.972                 0.63             POSITIVE
                                                   S-Adenosyl-4-methylthio-2-oxobutanoate      398.1069           8.901                 0.65             POSITIVE
                                                   p-Nitroglutethimide                         261.08979          5.377                 1.34             NEGATIVE
                                                   N-Methylethanolamine phosphate              156.03971          0.700                 1.44             POSITIVE
                                                   Citraconic acid                             129.02042          1.045                 1.48             NEGATIVE
                                                   Ascorbalamic acid                           262.0594           0.826                 1.48             NEGATIVE
                                                   p-Coumaroyl quinic acid                     339.10751          7.303                 1.56             POSITIVE
                                                   Caffeic acid 3-O-glucuronide                355.06987          3.773                 1.61             NEGATIVE
                                                   Ethyl (S)-3-hydroxybutyrate glucoside       293.1259           5.013                 1.62             NEGATIVE
                                                   1-Linoleoylglycerophosphocholine            520.33997          11.871                1.77             POSITIVE
                                                   Glucocaffeic acid                           341.09185          4.189                 1.88             NEGATIVE
                                                   Phenprocoumon                               279.11064          3.206                 1.98             NEGATIVE
                                                   DHAP(8:0)                                   295.09632          1.470                 2.53             NEGATIVE
                                                   Biocytin                                    104.03656          0.774                 2.68             NEGATIVE
                                                   Limocitrin 3-rutinoside                     655.19317          8.047                 2.69             POSITIVE
                                                   Rhamnocitrin 3-(6′-acetylglucoside)         505.1321           7.805                 3.53             POSITIVE
                                                   Methyl pentenoic acid                       115.07536          4.405                 3.88             POSITIVE
                                                   Cinnamic acid                               149.05952          4.721                 5.72             POSITIVE
                                                   Octenoic acid                               143.10642          8.313                 20.31            POSITIVE

###### The primers used for qRT-PCR.

  Category                                       Gene Name               Description             Sequence (5′-3′)           Sequence ID\* or reference   
  -------------------------------------------- ------------- ----------------------------------- -------------------------- ---------------------------- ------------------------
  Citrate synthesis-related                       *PEPC1*      phosphoenolpyruvate carboxylase   GTGCGATCCCGTCTATCTGT       AAGGCTCAAGGCCACTTTTT            orange1.1g002089m
                                                  *PEPC2*                                        GGCATGCAAAACACTGGTTA       CATGTTCATTACGGCTTGGA            orange1.1g002112m
                                                  *PEPC3*                                        GAACAATGACGGACACAACG       TGGACTCGCTTCCAACTTCT            orange1.1g001537m
                                                   *CS1*              citrate synthase           GGTGCCCCCAATATTAACAA       AGAGCTCGGTCCCATATCAA            orange1.1g012107m
                                                   *CS2*                                         ACTGGTGTATGGATGCGACA       TCTTCGTCTTGTGGCATTTG            orange1.1g010304m
  Citrate degradation or utilization-related      *Aco1*                  aconitase              GGCAAGTCATTCACATGCGTT      TGAAGAAGTAGACCCCGGTTGA         Terol *et al*.[@b29]
                                                  *Aco2*                                         GGCAATGATGAAGTGATGGCT      GTTGGAACATGGACCGTCTTT                    
                                                  *Aco3*                                         TGCAGCAATGAGGTACAAGGC      TCACACCCAGAAGCATTGGAC                    
                                                  *ACLα1*           ATP-citrate α subunit        GATACTGTTGGAGACTTGGG       GCTCTCTTACGACCATCAGG            Hu *et al*.[@b26]
                                                  *ACLα2*                                        TACAGTGGAGCACCCAACGA       CCTTCAGGGCTTGGATTATG                     
                                                  *ACLβ*            ATP-citrate β subunit        GAGGAGATAACAGAGACAAA       AACAAAGAGCCCATTCAGAT                     
                                                *NAD-IDH1*      NAD-isocitrate dehydrogenase     TATTGCTGGAGGCACTGGTG       ACTTCCCCTCTGCAATTGTG             orange1.1g018224
                                                *NAD-IDH2*                                       CAGCACCTGATATTGCTGGA       CTCTGCAATTGTGCTCAGGA             Ciclev10025889m
                                                *NAD-IDH3*                                       AGCAGGAAACGTGGGTAATG       GGCAGCAATAACAGCATCAA             orange1.1g017413
                                                *NADP-IDH1*     NADP-isocitrate dehydrogenase    GAAAATTGGGGATTGGGATT       CAACAGAGGTGCAGCTCAAA             orange1.1g015012
                                                *NADP-IDH2*                                      CAGCGGACATGTGAACAATC       CCGTCCATTTCAACGATAGG              Ciclev10005058
                                                *NADP-IDH3*                                      TACCGGGTTCATCAGAAAGG       AGGCTGCTTCCAGTTTCTCA             orange1.1g009041
                                                   *GS1*            glutamine synthetase         CATCAATGCTATCGCGTGTT       TCTGCATTCTTGGCAGGTTA            orange1.1g013478m
                                                   *GS2*                                         TTTGGGATGCTCAGTTGTGA       CTGAATGGCTCCCAAAAATG            orange1.1g018391m
                                                   *GS3*                                         TCAGGATTCACGAGTTCACG       AGCAAAGAACCCACTGTTGC            orange1.1g018434m
                                                  *GAD1*           glutamate decarboxylase       CACCAAAAAGAATGAGGAGACC     CCGTACTTGTGACCACTGACAT          Liu *et al*.[@b31]
                                                  *GAD2*                                         ACCGCAATGTGATGGAGAA        GAATTCATCGTGGCGTTTG                      
                                                 *PEPCK1*     phosphoenolpyruvate carboxykinase  GGCTACCGAGAATCCAAACA       GTGCTGGGTGTCGATCTCTT            orange1.1g005865m
                                                 *PEPCK2*                                        GGCTAGCGAAGATTCAAACG       GTCCCTTTAATGGGGGTGTT            orange1.1g006486m
                                                 *FBPase1*       fructose-1,6-bisphosphatase     TGGAAAGCTGAGGCTCTTGT       ACTTCCTCCTGGCTTCCAAT            orange1.1g015111m
                                                 *FBPase2*                                       TCCCATTTCTGATCAACTTTCC     GCTGAGGAGCAGGCTTTTTA            orange1.1g019437m
  Citrate transported-related                    *CsCit1*          H^+^/citrate symporter        GTCTCCGTAACAGGCATTGG       ACCACTAAGGGAAGCGTTCA          Shimada *et al*.[@b25]
                                                  *CsPH8*            p-type proton pump          CCGTGAAGGAATTGATTTGG       CCATGACAATGGATTCCACA            Shi *et al*.[@b23]
                                                 *VHA-af*            VHA assembly factor         CAGTGCTACTGAACCCTTCTCCTC   ATGCTCTGAATGCTAAATACCCAA        orange1.1g028366m
                                                  *VHA-A*          V-type ATPase A subunit       GATGCCCTTTTCCCTTCAGT       TTTCATTTCCTCGCTCCCCA             Ciclev10030969m
                                                  *VHA-B*          V-type ATPase B subunit       TCAATGTCCTTCCGTCCCTA       TTCTTCTCCGACCACAGCCT            orange1.1g011329m
                                                  *VHA-C*          V-type ATPase C subunit       AAACATTCATTTGACACTCCTCTT   AACTACTCTCTATGCCTGATACCC         Ciclev10015638m
                                                  *VHA-D*          V-type ATPase D subunit       ATTCTTCCTTTGCCCTGATTG      TTTCACATAAGCAGCACGACA            Ciclev10009240m
                                                 *VHA-E1*          V-type ATPase E subunit       CCGTACCGTCTGTCTTTCCTT      ACATCAGCGTCGTTCATTTTC           orange1.1g027450m
                                                 *VHA-E2*                                        AAGAGTGCTGATTCTCACGAACC    CGAGCAAGAAGGTTCGTGAG               Cs6g10330.1
                                                 *VHA-F1*          V-type ATPase F subunit       ATGGCTGGCAGAGCTCAAAT       CATCTTCAATTGCTTTCACCGTAG         Ciclev10002833m
                                                 *VHA-F2*                                        GCTTGCTGGAGTTGGGAATG       GCAGGGATCGGCTTGTTATG             Ciclev10022651m
                                                  *VHA-G*          V-type ATPase G subunit       GACTGAGGCAAGCCAAAGAAGA     AGCCCCAGCATTAAGATGATGA             Cs6g11650.2
                                                 *VHA-H1*          V-type ATPase H subunit       CTGTCGCTTGCTTTGATTTGTC     AACCTCGGTATTCTCATGGTTC          orange1.1g034108m
                                                 *VHA-H2*                                        CAGTGGAGTACTTGGCAACTA      TCCTTCAAACCTTCTTCCAGTTG            Cs7g14520.1
                                                 *VHA-a1*          V-type ATPase a subunit       TGGTAAGAAGAGAGAAGGCTGTAT   CTTGCGAGTTGCTATCAAATGT          orange1.1g003454m
                                                 *VHA-a2*                                        AAAAGTGTCTTGTGGGTGAGGG     GCGAAAATAGGTAGGCGGAG               Cs8g08330.1
                                                 *VHA-c1*          V-type ATPase c subunit       CGCCCTTGTCTTCTCCTGTAT      GACTTGGCCTTGGGGTTAATC              Cs8g07570.1
                                                 *VHA-c2*                                        TAACGCACAGCAGCCTAAGTTG     GATGAGAGGATGATTCCCACGA          orange1.1g031149m
                                                 *VHA-c3*                                        GTATGGGACGGCGAAGAGTG       CAAGCGAGACCCGAAGACAA               Cs1g25080.1
                                                 *VHA-c4*                                        GTACCGGAATTAACCCTAAGGC     CCAGCGGAGAGACCAGCAAG             Ciclev10002781m
                                                 *VHA-c"*         V-type ATPase c" subunit       TCACCATATACCTTCTCCGCC      ATAATTGCAACAATGACCCCA              Cs4g20460.1
                                                  *VHA-d*          V-type ATPase d subunit       CTTGGAGGCGATCGTGAGG        TACGACGATCATCTCGGGTG            orange1.1g018709m
                                                  *VHA-e*          V-type ATPase e subunit       ATGGGGTTTTTGGTGACA         TCACTCCTCTTCACTCAG               Ciclev10010112m
                                                  *VHP1*                V-type Ppase             CGAGCAGCAACAGCGACAAGA      CCACAGACCCCAGGAAAACGA            Ciclev10024946m
                                                  *VHP2*                                         TGAGCCACAGAATCAGAGAGAGAA   GCACCAACAATCAAACCAATAAAC         Ciclev10007524m
                                                  *VHP3*                                         CCCTGCACATACAACACAG        TGCTGACTCCTTTCCTTGCT            orange1.1g040141m
                                                  *VHP4*                                         GTTGTGTCTTGGGGTGGTCTTT     GCCTTCAGCTCCATCTCGTATT          orange1.1g003697m
  Actin                                           *Actin*                                        CCGACCGTATGAGCAAGGAAA      TTCCTGTGGACAATGGATGGA           Liu *et al*.[@b1]

[^1]: These authors contributed equally to this work.
